Glück Conviction Score™ ⓘ
INSM
INSMED Inc
Effektiv: Neutral
Hoch
Bedeutung der Einstufung ⓘ
Insider
0,0
Keine Insider-Käufe
Institutionell
44,7
93 neu, 288 erhöht, -4407329K $ netto
Aktivist
29,6
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)
Score-Verlauf (90 Tage)
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (12 Monate)
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bärisch | 10 % | 124.64 | -21.5 % vs SMA50 | |
| Kurs vs SMA200 | Bärisch | 15 % | 154.40 | -36.6 % vs SMA200 | |
| SMA-Cross | Bärisch | 10 % | DEATH | vor 50 Tagen @ 164.86 | |
| EMA20 vs EMA50 | Bärisch | 5 % | 104.48 | EMA50: 118.95 | |
| MACD-Histogramm | Bullisch | 10 % | 0.366 | Bullisch | |
| RSI(14) | Neutral | 10 % | 38.4 | Neutral (30–70) | |
| Stoch %K(14) | Neutral | 5 % | 38.1 | Neutral | |
| ADX(14)+DI | Bärisch | 10 % | 45.3 | +DI: 10.3 / −DI: 32.5 | |
| Z-Score(60) | Neutral | 5 % | -1.38 | In Range | |
| 52W-Position | Bärisch | 5 % | 5.0 % | Hoch 211.41 / Tief 91.88 | |
| Bollinger(20,2σ) | Neutral | 5 % | 24.4 % | Upper 114.57 / Mid 103.52 / Lower 92.46 | |
| LinReg-Slope(60) | Bärisch | 10 % | -1.1614 | R²=0.81 / annualisiert -227.5 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-06-08 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -6.515 | 94,03 | -612.605,45 | -61,2% | |
| 2026-06-05 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -1.858 | 103,78 | -192.823,24 | -19,3% | |
| 2026-06-03 | Adsett Roger | Officer, Chief Operating Officer | Open Market Sale | -2.370 | 102,27 | -242.379,90 | -24,2% | |
| 2026-06-03 | Bonstein Sara | Officer, Chief Financial Officer | Open Market Sale | -2.404 | 102,27 | -245.857,08 | -24,6% | |
| 2026-06-03 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -2.159 | 102,27 | -220.800,93 | -22,1% | |
| 2026-06-03 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -2.566 | 102,27 | -262.424,82 | -26,2% | |
| 2026-06-03 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -7.605 | 102,27 | -777.763,35 | -77,7% | |
| 2026-05-22 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -6.149 | 108,47 | -666.982,03 | -66,7% | |
| 2026-05-18 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -5.753 | 105,32 | -605.905,96 | -60,6% | |
| 2026-05-18 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -11.836 | 106,39 | -1.259.232,04 | -125,9% | |
| 2026-05-18 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -7.975 | 106,97 | -853.085,75 | -85,3% | |
| 2026-05-14 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -10.479 | 117,54 | -1.231.701,66 | -123,1% | |
| 2026-05-13 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -3.384 | 116,18 | -393.153,12 | -39,3% | |
| 2026-05-13 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -13.283 | 116,18 | -1.543.218,94 | -154,2% | |
| 2026-05-13 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -4.109 | 116,18 | -477.383,62 | -47,7% | |
| 2026-05-13 | Bonstein Sara | Officer, Chief Financial Officer | Open Market Sale | -8.272 | 116,18 | -961.040,96 | -96,0% | |
| 2026-05-13 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -4.470 | 112,76 | -504.037,20 | -50,4% | |
| 2026-05-13 | Adsett Roger | Officer, Chief Operating Officer | Open Market Sale | -5.837 | 116,18 | -678.142,66 | -67,8% | |
| 2026-05-11 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -12.119 | 100,35 | -1.216.141,65 | -121,5% | |
| 2026-05-11 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -830 | 101,18 | -83.979,40 | -8,4% | |
| 2026-05-04 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1.247 | 139,09 | -173.445,23 | -17,3% | |
| 2026-05-04 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -5.318 | 137,01 | -728.619,18 | -72,8% | |
| 2026-05-04 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -2.721 | 137,86 | -375.117,06 | -37,5% | |
| 2026-05-04 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -599 | 135,18 | -80.972,82 | -8,1% | |
| 2026-05-04 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -433 | 134,18 | -58.099,94 | -5,8% | |
| 2026-05-04 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -381 | 139,60 | -53.187,60 | -5,3% | |
| 2026-04-16 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -2.246 | 142,99 | -321.155,54 | -32,1% | |
| 2026-04-16 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -5.373 | 143,81 | -772.691,13 | -77,2% | |
| 2026-04-16 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -2.255 | 144,66 | -326.208,30 | -32,6% | |
| 2026-04-16 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -825 | 145,79 | -120.276,75 | -12,0% | |
| 2026-04-06 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1.434 | 164,01 | -235.190,34 | -23,5% | |
| 2026-04-06 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -8.478 | 163,23 | -1.383.863,94 | -138,3% | |
| 2026-04-06 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -787 | 161,73 | -127.281,51 | -12,7% | |
| 2026-04-01 | Adsett Roger | Officer, Chief Operating Officer | Open Market Sale | -19.001 | 164,11 | -3.118.254,11 | -311,6% | |
| 2026-04-01 | Adsett Roger | Officer, Chief Operating Officer | Open Market Sale | -62.344 | 164,95 | -10.283.642,80 | -1027,8% | |
| 2026-04-01 | Adsett Roger | Officer, Chief Operating Officer | Open Market Sale | -6.715 | 163,18 | -1.095.753,70 | -109,5% | |
| 2026-03-30 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -19.638 | 150,98 | -2.964.945,24 | -296,3% | |
| 2026-03-19 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1.629 | 142,17 | -231.594,93 | -23,1% | |
| 2026-03-19 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -4.537 | 143,42 | -650.696,54 | -65,0% | |
| 2026-03-19 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -4.533 | 144,11 | -653.250,63 | -65,3% | |
| 2026-03-05 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -2.083 | 144,23 | -300.431,09 | -30,0% | |
| 2026-03-05 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -3.899 | 146,66 | -571.827,34 | -57,1% | |
| 2026-03-05 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -2.589 | 145,27 | -376.104,03 | -37,6% | |
| 2026-03-05 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -2.128 | 147,54 | -313.965,12 | -31,4% | |
| 2026-02-24 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -15.771 | 156,53 | -2.468.634,63 | -246,7% | |
| 2026-02-24 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -4.151 | 155,06 | -643.654,06 | -64,3% | |
| 2026-02-24 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -4.852 | 153,93 | -746.868,36 | -74,6% | |
| 2026-02-19 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1.030 | 153,38 | -157.981,40 | -15,8% | |
| 2026-02-19 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -3.413 | 151,12 | -515.772,56 | -51,5% | |
| 2026-02-19 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -2.377 | 151,92 | -361.113,84 | -36,1% | |
| 2026-02-19 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1.988 | 149,17 | -296.549,96 | -29,6% | |
| 2026-02-19 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1.891 | 150,10 | -283.839,10 | -28,4% | |
| 2026-02-09 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -7.221 | 148,02 | -1.068.852,42 | -106,8% | |
| 2026-02-09 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -4.888 | 147,17 | -719.366,96 | -71,9% | |
| 2026-02-09 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1.287 | 148,83 | -191.544,21 | -19,1% | |
| 2026-02-05 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -869 | 152,44 | -132.470,36 | -13,2% | |
| 2026-02-03 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -795 | 155,77 | -123.837,15 | -12,4% | |
| 2026-02-03 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -640 | 156,27 | -100.012,80 | -10,0% | |
| 2026-02-03 | Adsett Roger | Officer, Chief Operating Officer | Open Market Sale | -791 | 156,17 | -123.530,47 | -12,3% | |
| 2026-02-03 | Bonstein Sara | Officer, Chief Financial Officer | Open Market Sale | -748 | 156,34 | -116.942,32 | -11,7% | |
| 2026-02-03 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -3.009 | 156,34 | -470.427,06 | -47,0% | |
| 2026-02-02 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -563 | 152,06 | -85.609,78 | -8,6% | |
| 2026-02-02 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -3.349 | 154,56 | -517.621,44 | -51,7% | |
| 2026-02-02 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -3.042 | 155,46 | -472.909,32 | -47,3% | |
| 2026-02-02 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -928 | 153,16 | -142.132,48 | -14,2% | |
| 2026-02-02 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -100 | 156,86 | -15.686,00 | -1,6% | |
| 2026-01-20 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1.006 | 156,80 | -157.740,80 | -15,8% | |
| 2026-01-20 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -5.967 | 158,99 | -948.693,33 | -94,8% | |
| 2026-01-20 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -2.229 | 159,85 | -356.305,65 | -35,6% | |
| 2026-01-20 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1.243 | 158,37 | -196.853,91 | -19,7% | |
| 2026-01-20 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -254 | 160,70 | -40.817,80 | -4,1% | |
| 2026-01-12 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -7.176 | 168,63 | -1.210.088,88 | -120,9% | |
| 2026-01-12 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -6.996 | 169,57 | -1.186.311,72 | -118,6% | |
| 2026-01-12 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -3.974 | 167,73 | -666.559,02 | -66,6% | |
| 2026-01-12 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -315 | 174,86 | -55.080,90 | -5,5% | |
| 2026-01-12 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -297 | 172,36 | -51.190,92 | -5,1% | |
| 2026-01-12 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -297 | 171,31 | -50.879,07 | -5,1% | |
| 2026-01-12 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -160 | 170,24 | -27.238,40 | -2,7% | |
| 2026-01-09 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -1.887 | 186,19 | -351.340,53 | -35,1% | |
| 2026-01-08 | Bonstein Sara | Officer, Chief Financial Officer | Open Market Sale | -1.447 | 174,17 | -252.023,99 | -25,2% | |
| 2026-01-08 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -3.223 | 174,17 | -561.349,91 | -56,1% | |
| 2026-01-08 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -1.053 | 174,17 | -183.401,01 | -18,3% | |
| 2026-01-08 | Adsett Roger | Officer, Chief Operating Officer | Open Market Sale | -2.059 | 174,17 | -358.616,03 | -35,8% | |
| 2026-01-08 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -3.251 | 174,17 | -566.226,67 | -56,6% | |
| 2026-01-08 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -1.660 | 173,87 | -288.624,20 | -28,8% | |
| 2026-01-07 | Adsett Roger | Officer, Chief Operating Officer | Open Market Sale | -802 | 175,07 | -140.406,14 | -14,0% | |
| 2026-01-07 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -1.434 | 175,84 | -252.154,56 | -25,2% | |
| 2026-01-07 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -709 | 175,07 | -124.124,63 | -12,4% | |
| 2026-01-07 | Bonstein Sara | Officer, Chief Financial Officer | Open Market Sale | -1.678 | 175,07 | -293.767,46 | -29,4% | |
| 2026-01-07 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -2.357 | 175,07 | -412.639,99 | -41,2% | |
| 2026-01-06 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -2.830 | 174,21 | -493.014,30 | -49,3% | |
| 2026-01-06 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -4.096 | 173,33 | -709.959,68 | -71,0% | |
| 2026-01-06 | Adsett Roger | Officer, Chief Operating Officer | Open Market Sale | -1.429 | 173,33 | -247.688,57 | -24,8% | |
| 2026-01-06 | Bonstein Sara | Officer, Chief Financial Officer | Open Market Sale | -1.517 | 173,33 | -262.941,61 | -26,3% | |
| 2026-01-06 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -1.396 | 173,33 | -241.968,68 | -24,2% | |
| 2026-01-06 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -1.615 | 173,33 | -279.927,95 | -28,0% | |
| 2026-01-06 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -4.783 | 173,47 | -829.707,01 | -82,9% | |
| 2026-01-06 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -957 | 175,01 | -167.484,57 | -16,7% | |
| 2026-01-05 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -3.205 | 170,61 | -546.805,05 | -54,6% | |
| 2026-01-05 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -286 | 171,92 | -49.169,12 | -4,9% | |
| 2026-01-05 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -702 | 175,73 | -123.362,46 | -12,3% | |
| 2026-01-05 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -655 | 174,28 | -114.153,40 | -11,4% | |
| 2026-01-05 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -1.820 | 173,45 | -315.679,00 | -31,5% | |
| 2026-01-05 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -2.799 | 169,29 | -473.842,71 | -47,4% | |
| 2026-01-05 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -2.836 | 171,19 | -485.494,84 | -48,5% | |
| 2026-01-02 | Schaeffer Orlov S Nicole | Officer, Chief People Strategy Officer | Open Market Sale | -12.832 | 176,08 | -2.259.458,56 | -225,8% | |
| 2026-01-02 | Schaeffer Orlov S Nicole | Officer, Chief People Strategy Officer | Open Market Sale | -200 | 177,78 | -35.556,00 | -3,6% | |
| 2026-01-02 | Schaeffer Orlov S Nicole | Officer, Chief People Strategy Officer | Open Market Sale | -9.125 | 177,17 | -1.616.676,25 | -161,6% | |
| 2026-01-02 | Schaeffer Orlov S Nicole | Officer, Chief People Strategy Officer | Open Market Sale | -31.030 | 174,28 | -5.407.908,40 | -540,5% | |
| 2026-01-02 | Schaeffer Orlov S Nicole | Officer, Chief People Strategy Officer | Open Market Sale | -34.103 | 175,17 | -5.973.822,51 | -597,0% | |
| 2025-12-18 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -51 | 171,20 | -8.731,20 | -0,9% | |
| 2025-12-18 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -2.175 | 168,54 | -366.574,50 | -36,6% | |
| 2025-12-18 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1.938 | 169,58 | -328.646,04 | -32,8% | |
| 2025-12-18 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1.783 | 166,60 | -297.047,80 | -29,7% | |
| 2025-12-18 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1.465 | 163,19 | -239.073,35 | -23,9% | |
| 2025-12-18 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1.431 | 167,29 | -239.391,99 | -23,9% | |
| 2025-12-18 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -697 | 165,21 | -115.151,37 | -11,5% | |
| 2025-12-18 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -447 | 164,24 | -73.415,28 | -7,3% | |
| 2025-12-18 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -362 | 170,26 | -61.634,12 | -6,2% | |
| 2025-12-18 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -350 | 162,26 | -56.791,00 | -5,7% | |
| 2025-12-05 | SHAROKY MELVIN MD | Director | Open Market Sale | -20.000 | 205,01 | -4.100.200,00 | -409,8% | |
| 2025-12-04 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -2.222 | 205,66 | -456.976,52 | -45,7% | |
| 2025-12-04 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -4.516 | 204,62 | -924.063,92 | -92,4% | |
| 2025-12-04 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -2.921 | 206,49 | -603.157,29 | -60,3% | |
| 2025-12-04 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1.040 | 207,42 | -215.716,80 | -21,6% | |
| 2025-12-01 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -1.450 | 205,98 | -298.671,00 | -29,8% | |
| 2025-12-01 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -5.886 | 207,03 | -1.218.578,58 | -121,8% | |
| 2025-12-01 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -1.559 | 207,73 | -323.851,07 | -32,4% | |
| 2025-11-24 | ANDERSON ELIZABETH M | Director | Open Market Sale | -5.000 | 204,58 | -1.022.900,00 | -102,2% | |
| 2025-11-17 | LEE LEO | Director | Open Market Sale | -17.594 | 194,49 | -3.421.857,06 | -342,0% | |
| 2025-11-17 | LEE LEO | Director | Open Market Sale | -24.076 | 196,61 | -4.733.582,36 | -473,1% | |
| 2025-11-17 | LEE LEO | Director | Open Market Sale | -15.174 | 197,40 | -2.995.347,60 | -299,4% | |
| 2025-11-17 | LEE LEO | Director | Open Market Sale | -14.944 | 195,39 | -2.919.908,16 | -291,8% | |
| 2025-11-17 | LEE LEO | Director | Open Market Sale | -3.212 | 193,51 | -621.554,12 | -62,1% | |
| 2025-11-14 | ANDERSON ELIZABETH M | Director | Open Market Sale | -10.000 | 195,87 | -1.958.700,00 | -195,8% | |
| 2025-11-11 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -10.622 | 190,33 | -2.021.685,26 | -202,1% | |
| 2025-11-11 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -5.467 | 188,38 | -1.029.873,46 | -102,9% | |
| 2025-11-11 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -2.913 | 191,04 | -556.499,52 | -55,6% | |
| 2025-11-11 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -12.224 | 189,36 | -2.314.736,64 | -231,3% | |
| 2025-11-03 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -3.243 | 184,91 | -599.663,13 | -59,9% | |
| 2025-11-03 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -1.572 | 187,15 | -294.199,80 | -29,4% | |
| 2025-11-03 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -1.342 | 181,01 | -242.915,42 | -24,3% | |
| 2025-11-03 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -1.400 | 187,97 | -263.158,00 | -26,3% | |
| 2025-11-03 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -7.619 | 181,88 | -1.385.743,72 | -138,5% | |
| 2025-11-03 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -4.286 | 182,60 | -782.623,60 | -78,2% | |
| 2025-11-03 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -4.032 | 183,92 | -741.565,44 | -74,1% | |
| 2025-11-03 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -3.636 | 185,93 | -676.041,48 | -67,6% | |
| 2025-09-12 | Schaeffer Orlov S Nicole | Officer, Chief People Strategy Officer | Open Market Sale | -30.967 | 145,67 | -4.510.962,89 | -450,8% | |
| 2025-09-12 | SHAROKY MELVIN MD | Director | Open Market Sale | -10.000 | 145,39 | -1.453.900,00 | -145,3% | |
| 2025-09-12 | Schaeffer Orlov S Nicole | Officer, Chief People Strategy Officer | Open Market Sale | -6.158 | 147,46 | -908.058,68 | -90,8% | |
| 2025-09-12 | Schaeffer Orlov S Nicole | Officer, Chief People Strategy Officer | Open Market Sale | -32.091 | 144,60 | -4.640.358,60 | -463,8% | |
| 2025-09-12 | Schaeffer Orlov S Nicole | Officer, Chief People Strategy Officer | Open Market Sale | -7.304 | 146,57 | -1.070.547,28 | -107,0% | |
| 2025-09-02 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -1.354 | 141,16 | -191.130,64 | -19,1% | |
| 2025-09-02 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -8.300 | 144,16 | -1.196.528,00 | -119,6% | |
| 2025-09-02 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -7.391 | 143,16 | -1.058.095,56 | -105,7% | |
| 2025-09-02 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -4.944 | 145,18 | -717.769,92 | -71,7% | |
| 2025-09-02 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -1.183 | 145,89 | -172.587,87 | -17,2% | |
| 2025-09-02 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -1.100 | 142,06 | -156.266,00 | -15,6% | |
| 2025-09-02 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -63.782 | 145,33 | -9.269.438,06 | -926,4% | |
| 2025-09-02 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -35.245 | 143,16 | -5.045.674,20 | -504,3% | |
| 2025-09-02 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -34.615 | 146,05 | -5.055.520,75 | -505,3% | |
| 2025-09-02 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -28.063 | 144,05 | -4.042.475,15 | -404,0% | |
| 2025-09-02 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -19.066 | 141,27 | -2.693.453,82 | -269,2% | |
| 2025-09-02 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -5.877 | 142,03 | -834.710,31 | -83,4% | |
| 2025-08-20 | SHAROKY MELVIN MD | Director | Open Market Sale | -10.000 | 129,50 | -1.295.000,00 | -129,4% | |
| 2025-08-19 | Adsett Roger | Officer, Chief Operating Officer | Open Market Sale | -20.193 | 127,42 | -2.572.992,06 | -257,2% | |
| 2025-08-19 | Adsett Roger | Officer, Chief Operating Officer | Open Market Sale | -4.807 | 128,27 | -616.593,89 | -61,6% | |
| 2025-08-18 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1.416 | 129,47 | -183.329,52 | -18,3% | |
| 2025-08-18 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -2.968 | 127,59 | -378.687,12 | -37,8% | |
| 2025-08-18 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -2.481 | 128,76 | -319.453,56 | -31,9% | |
| 2025-08-14 | Schaeffer Orlov S Nicole | Officer, Chief People Strategy Officer | Open Market Sale | -700 | 128,16 | -89.712,00 | -9,0% | |
| 2025-08-14 | Schaeffer Orlov S Nicole | Officer, Chief People Strategy Officer | Open Market Sale | -5.746 | 127,71 | -733.821,66 | -73,3% | |
| 2025-08-14 | Schaeffer Orlov S Nicole | Officer, Chief People Strategy Officer | Open Market Sale | -3.554 | 126,57 | -449.829,78 | -45,0% | |
| 2025-08-12 | SHAROKY MELVIN MD | Director | Open Market Sale | -10.000 | 121,58 | -1.215.800,00 | -121,5% | |
| 2025-08-04 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1.693 | 108,80 | -184.198,40 | -18,4% | |
| 2025-08-04 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -3.199 | 109,68 | -350.866,32 | -35,1% | |
| 2025-08-04 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1.938 | 110,91 | -214.943,58 | -21,5% | |
| 2025-08-04 | Flammer Martina M.D. | Officer, Chief Medical Officer | Open Market Sale | -8.715 | 109,50 | -954.292,50 | -95,4% | |
| 2025-07-21 | Bonstein Sara | Officer, Chief Financial Officer | Open Market Sale | -32.090 | 102,38 | -3.285.374,20 | -328,3% | |
| 2025-07-21 | Bonstein Sara | Officer, Chief Financial Officer | Open Market Sale | -26.310 | 103,03 | -2.710.719,30 | -270,9% | |
| 2025-07-15 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -2.168 | 101,71 | -220.507,28 | -22,0% | |
| 2025-07-15 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -933 | 102,51 | -95.641,83 | -9,6% | |
| 2025-07-15 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -170 | 103,32 | -17.564,40 | -1,8% | |
| 2025-07-15 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -4.492 | 102,66 | -461.148,72 | -46,1% | |
| 2025-07-11 | Smith Michael Alexander | Officer, Chief Legal Officer | Open Market Sale | -748 | 96,41 | -72.114,68 | -7,2% | |
| 2025-07-07 | Bonstein Sara | Officer, Chief Financial Officer | Open Market Sale | -35.583 | 95,66 | -3.403.869,78 | -340,2% | |
| 2025-07-07 | Bonstein Sara | Officer, Chief Financial Officer | Open Market Sale | -22.181 | 96,19 | -2.133.590,39 | -213,2% | |
| 2025-07-01 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -2.349 | 98,83 | -232.151,67 | -23,2% | |
| 2025-07-01 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -3.666 | 97,73 | -358.278,18 | -35,8% | |
| 2025-07-01 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -815 | 99,61 | -81.182,15 | -8,1% | |
| 2025-06-23 | Bonstein Sara | Officer, Chief Financial Officer | Open Market Sale | -49.104 | 101,71 | -4.994.367,84 | -499,2% | |
| 2025-06-23 | Bonstein Sara | Officer, Chief Financial Officer | Open Market Sale | -8.661 | 102,15 | -884.721,15 | -88,4% | |
| 2025-06-16 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -1.558 | 99,65 | -155.254,70 | -15,5% | |
| 2025-06-16 | Adsett Roger | Officer, Chief Operating Officer | Open Market Sale | -6.500 | 98,50 | -640.250,00 | -64,0% | |
| 2025-06-16 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -442 | 98,51 | -43.541,42 | -4,4% | |
| 2025-06-16 | Adsett Roger | Officer, Chief Operating Officer | Open Market Sale | -4.186 | 99,32 | -415.753,52 | -41,6% | |
| 2025-06-16 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -48.531 | 100,54 | -4.879.306,74 | -487,7% | |
| 2025-06-16 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -41.784 | 101,23 | -4.229.794,32 | -422,7% | |
| 2025-06-16 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -32.490 | 99,51 | -3.233.079,90 | -323,1% | |
| 2025-06-16 | Lewis William | Director, Officer, Chair and CEO | Open Market Sale | -7.000 | 98,50 | -689.500,00 | -68,9% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| JPMORGAN CHASE & CO | 23.556.212 | 0 | 23.556.212 | 4.099.723.379 | Neu | +100,0% | |
| VANGUARD GROUP INC | 21.076.344 | 0 | 21.076.344 | 3.668.126.910 | Neu | +100,0% | |
| BlackRock, Inc. | 16.678.146 | 15.065.052 | 1.613.094 | 2.727.210.442 | Aufgestockt | +10,7% | |
| Darwin Global Management, Ltd. | 16.805.184 | 20.933.277 | -4.128.093 | 2.576.570.811 | Reduziert | -19,7% | |
| FMR LLC | 13.160.167 | 9.927.936 | 3.232.231 | 2.151.950.430 | Aufgestockt | +32,6% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 9.642.131 | 0 | 9.642.131 | 1.576.681.262 | Neu | +100,0% | |
| BAKER BROS. ADVISORS LP | 7.421.111 | 6.592.746 | 828.365 | 1.213.500.071 | Aufgestockt | +12,6% | |
| Artisan Partners Limited Partnership | 6.527.301 | 4.843.749 | 1.683.552 | 1.067.344.315 | Aufgestockt | +34,8% | |
| D. E. Shaw & Co., Inc. | 5.642.725 | 4.364.695 | 1.278.030 | 922.698.392 | Aufgestockt | +29,3% | |
| Capital International Investors | 5.595.194 | 5.151.671 | 443.523 | 914.890.382 | Aufgestockt | +8,6% | |
| STATE STREET CORP | 5.551.699 | 5.201.744 | 349.955 | 907.813.820 | Aufgestockt | +6,7% | |
| RTW INVESTMENTS, LP | 4.842.880 | 4.842.879 | 1 | 791.907.738 | Aufgestockt | 0,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 4.450.389 | 4.299.052 | 151.337 | 733.323.353 | Aufgestockt | +3,5% | |
| NORGES BANK | 2.910.971 | 0 | 2.910.971 | 506.625.393 | Neu | +100,0% | |
| AMERIPRISE FINANCIAL INC | 3.057.718 | 1.968.857 | 1.088.861 | 499.999.046 | Aufgestockt | +55,3% | |
| FRANKLIN RESOURCES INC | 2.617.251 | 2.755.536 | -138.285 | 427.972.899 | Reduziert | -5,0% | |
| CITADEL ADVISORS LLC | 2.613.071 | 1.808.995 | 804.076 | 427.289.370 | Aufgestockt | +44,4% | |
| Invesco Ltd. | 1.988.968 | 2.726.857 | -737.889 | 325.236.138 | Reduziert | -27,1% | |
| Orbis Allan Gray Ltd | 1.872.824 | 4.179.957 | -2.307.133 | 306.244.181 | Reduziert | -55,2% | |
| UBS Group AG | 1.737.481 | 1.950.835 | -213.354 | 284.112.894 | Reduziert | -10,9% | |
| BANK OF AMERICA CORP /DE/ | 1.502.281 | 1.725.681 | -223.400 | 245.652.979 | Reduziert | -12,9% | |
| Integral Health Asset Management, LLC | 1.500.000 | 1.250.000 | 250.000 | 245.280.000 | Aufgestockt | +20,0% | |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1.468.459 | 432.521 | 1.035.938 | 240.122.429 | Aufgestockt | +239,5% | |
| SEI INVESTMENTS CO | 1.395.794 | 890.170 | 505.624 | 228.239.457 | Aufgestockt | +56,8% | |
| Capital World Investors | 1.362.291 | 0 | 1.362.291 | 222.743.856 | Neu | +100,0% | |
| MORGAN STANLEY | 1.331.542 | 1.631.906 | -300.364 | 217.734.151 | Reduziert | -18,4% | |
| MILLENNIUM MANAGEMENT LLC | 1.295.086 | 1.312.854 | -17.768 | 211.772.463 | Reduziert | -1,4% | |
| NORTHERN TRUST CORP | 1.294.000 | 1.238.438 | 55.562 | 211.594.881 | Aufgestockt | +4,5% | |
| Castle Hook Partners LP | 1.269.754 | 1.253.568 | 16.186 | 207.630.174 | Aufgestockt | +1,3% | |
| Paradigm Biocapital Advisors LP | 1.254.488 | 0 | 1.254.488 | 205.133.878 | Neu | +100,0% | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1.215.025 | 943.306 | 271.719 | 198.680.888 | Aufgestockt | +28,8% | |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 1.143.739 | 1.183.029 | -39.290 | 187.024.000 | Reduziert | -3,3% | |
| Pictet Asset Management Holding SA | 1.102.248 | 958.963 | 143.285 | 178.658.787 | Aufgestockt | +14,9% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.078.930 | 2.392.776 | -1.313.846 | 176.426.634 | Reduziert | -54,9% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.069.390 | 1.027.355 | 42.035 | 174.866.653 | Aufgestockt | +4,1% | |
| Fiera Capital Corp | 1.021.970 | 992.892 | 29.078 | 167.112.534 | Aufgestockt | +2,9% | |
| GOLDMAN SACHS GROUP INC | 942.646 | 1.303.413 | -360.767 | 154.141.406 | Reduziert | -27,7% | |
| AMERICAN CENTURY COMPANIES INC | 925.799 | 185.090 | 740.709 | 151.387.667 | Aufgestockt | +400,2% | |
| PRINCIPAL FINANCIAL GROUP INC | 916.464 | 771.358 | 145.106 | 149.860.193 | Aufgestockt | +18,8% | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 902.666 | 1.221.096 | -318.430 | 147.603.944 | Reduziert | -26,1% | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 900.000 | 300.000 | 600.000 | 147.168.000 | Aufgestockt | +200,0% | |
| Holocene Advisors, LP | 801.165 | 0 | 801.165 | 139.434.757 | Neu | +100,0% | |
| FIL Ltd | 828.947 | 838.509 | -9.562 | 135.549.413 | Reduziert | -1,1% | |
| Amundi | 804.977 | 916.998 | -112.021 | 131.629.839 | Reduziert | -12,2% | |
| Legal & General Group Plc | 787.079 | 540.313 | 246.766 | 128.703.161 | Aufgestockt | +45,7% | |
| RAYMOND JAMES FINANCIAL INC | 775.148 | 779.254 | -4.106 | 121.375.450 | Reduziert | -0,5% | |
| ALLIANCEBERNSTEIN L.P. | 688.734 | 642.719 | 46.015 | 119.867.265 | Aufgestockt | +7,2% | |
| Hood River Capital Management LLC | 688.554 | 637.577 | 50.977 | 112.592.350 | Aufgestockt | +8,0% | |
| AQR CAPITAL MANAGEMENT LLC | 675.485 | 468.260 | 207.225 | 108.786.989 | Aufgestockt | +44,3% | |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 653.445 | 1.449.080 | -795.635 | 106.851.326 | Reduziert | -54,9% |
Top-Fondshalter (Stand: 31.03.2026) ⓘ
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) |
|---|---|---|---|---|---|
| JPMORGAN CHASE & CO | 24.255.499 | 23.556.212 | +3,0% | 3.718.853.370 | 11,64 |
| BlackRock, Inc. | 16.678.146 | 15.065.052 | +10,7% | 2.727.210.442 | 8,53 |
| Darwin Global Management, Ltd. | 16.805.184 | 20.933.277 | -19,7% | 2.576.570.811 | 8,06 |
| FMR LLC | 13.160.167 | 9.927.936 | +32,6% | 2.151.950.430 | 6,73 |
| VANGUARD CAPITAL MANAGEMENT LLC | 9.642.131 | 0 | +100,0% | 1.576.681.262 | 4,93 |
| BAKER BROS. ADVISORS LP | 7.421.111 | 6.592.746 | +12,6% | 1.213.500.071 | 3,80 |
| Artisan Partners Limited Partnership | 6.527.301 | 4.843.749 | +34,8% | 1.067.344.315 | 3,34 |
| D. E. Shaw & Co., Inc. | 5.642.725 | 4.364.695 | +29,3% | 922.698.392 | 2,89 |
| Capital International Investors | 5.595.194 | 5.151.671 | +8,6% | 914.890.382 | 2,86 |
| STATE STREET CORP | 5.551.699 | 5.201.744 | +6,7% | 907.813.820 | 2,84 |
| RTW INVESTMENTS, LP | 4.842.880 | 4.842.879 | 0,0% | 791.907.738 | 2,48 |
| GEODE CAPITAL MANAGEMENT, LLC | 4.450.389 | 4.299.052 | +3,5% | 733.323.353 | 2,29 |
| AMERIPRISE FINANCIAL INC | 3.057.718 | 1.968.857 | +55,3% | 499.999.046 | 1,56 |
| FRANKLIN RESOURCES INC | 2.617.251 | 2.755.536 | -5,0% | 427.972.899 | 1,34 |
| CITADEL ADVISORS LLC | 2.613.071 | 1.808.995 | +44,4% | 427.289.370 | 1,34 |
| Invesco Ltd. | 1.988.968 | 2.726.857 | -27,1% | 325.236.138 | 1,02 |
| Orbis Allan Gray Ltd | 1.872.824 | 4.179.957 | -55,2% | 306.244.181 | 0,96 |
| UBS Group AG | 1.737.481 | 1.950.835 | -10,9% | 284.112.894 | 0,89 |
| BANK OF AMERICA CORP /DE/ | 1.502.281 | 1.725.681 | -12,9% | 245.652.979 | 0,77 |
| Integral Health Asset Management, LLC | 1.500.000 | 1.250.000 | +20,0% | 245.280.000 | 0,77 |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 31.03.2026 | ✓ | 656 | 229,4 | 35.728 |
| 31.12.2025 | ✓ | 669 | 223,9 | 37.087 |
| 30.09.2025 | ✓ | 569 | 248,8 | 33.456 |
| 30.06.2025 | ✓ | 513 | 217,8 | 19.744 |
| 31.03.2025 | ✓ | 458 | 759,1 | 15.869 |
| 31.12.2024 | ✓ | 452 | 761,8 | 13.720 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) ⓘ |
|---|---|---|
| NORGES BANK | 2.910.971 | 506.625.393 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 1.183.029 | 205.894.000 |
| SUSQUEHANNA ADVISORS GROUP, INC. | 565.000 | 98.332.600 |
| Sumitomo Mitsui Trust Group, Inc. | 435.442 | 75.784.326 |
| GATEWAY INVESTMENT ADVISERS LLC | 365.000 | 63.524.600 |
| Zurich Insurance Group Ltd/FI | 281.098 | 48.922.296 |
| National Pension Service | 280.442 | 48.808.126 |
| Alberta Investment Management Corp | 206.532 | 35.944.829 |
| TREMBLANT CAPITAL GROUP | 175.650 | 30.570.126 |
| Perpetual Ltd | 141.517 | 24.629.618 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| BlackRock, Inc. | 15.065.052 | 2.700.148 | +21.8 % | 2.621.921.693 |
| RTW INVESTMENTS, LP | 4.842.879 | 1.758.321 | +57.0 % | 842.854.661 |
| STATE STREET CORP | 5.201.744 | 1.217.390 | +30.6 % | 905.311.526 |
| VANGUARD GROUP INC | 21.076.344 | 1.140.524 | +5.7 % | 3.668.126.910 |
| Orbis Allan Gray Ltd | 4.179.957 | 929.089 | +28.6 % | 727.479.716 |
| Jefferies Financial Group Inc. | 1.026.239 | 818.242 | +393.4 % | 178.606.636 |
| FMR LLC | 9.927.936 | 746.973 | +8.1 % | 1.727.857.942 |
| Invesco Ltd. | 2.726.857 | 722.986 | +36.1 % | 474.582.256 |
| MORGAN STANLEY | 1.631.906 | 668.275 | +69.3 % | 284.017.467 |
| FRANKLIN RESOURCES INC | 2.755.536 | 615.811 | +28.8 % | 479.573.482 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ | 4.039.466 | -2.892.000 | -41.7 % | 703.030 |
| Capital International Investors | 5.151.671 | -2.402.182 | -31.8 % | 896.597.082 |
| D. E. Shaw & Co., Inc. | 4.364.695 | -1.364.469 | -23.8 % | 759.631.518 |
| MILLENNIUM MANAGEMENT LLC | 1.312.854 | -1.023.258 | -43.8 % | 228.489.110 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 300.000 | -952.503 | -76.0 % | 52.212.000 |
| Duquesne Family Office LLC | 1.481.752 | -941.683 | -38.9 % | 257.884 |
| ROYAL BANK OF CANADA | 506.811 | -848.520 | -62.6 % | 88.205.000 |
| LORD, ABBETT & CO. LLC | 720.898 | -791.758 | -52.3 % | 125.465 |
| CITADEL ADVISORS LLC | 1.808.995 | -784.046 | -30.2 % | 314.837.490 |
| JANE STREET GROUP, LLC | 1.034.205 | -777.829 | -42.9 % | 179.993.038 |
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck |
|---|---|---|---|---|---|---|
| 15.05.2026 | Dr. Abhishek Trehan | Passiv (13G/A) | 7,80 % | 16.805.184 | -1,90 pp | |
| 15.05.2026 | Darwin Global Master Fund, Ltd. | Passiv (13G/A) | 6,60 % | 14.182.375 | -2,90 pp | |
| 15.05.2026 | Darwin Global Management, Ltd. | Passiv (13G/A) | 7,80 % | 16.805.184 | -1,90 pp | |
| 06.05.2026 | FMR LLC | Passiv (13G) | 6,10 % | 13.145.167 | Neu | |
| 06.05.2026 | Abigail P. Johnson | Passiv (13G) | 6,10 % | 13.145.167 | Neu | |
| 30.04.2026 | Vanguard Capital Management | Passiv (13G) | 5,34 % | 11.514.893 | Neu | |
| 27.03.2026 | The Vanguard Group | Passiv (13G/A) | Ausstieg | 0 | -10,18 pp | |
| 21.01.2026 | BlackRock, Inc. | Passiv (13G/A) | 6,60 % | 14.121.445 | +1,50 pp | |
| 14.11.2025 | Dr. Abhishek Trehan | Passiv (13G/A) | 9,70 % | 20.457.445 | +1,20 pp | |
| 14.11.2025 | Darwin Global Master Fund, Ltd. | Passiv (13G/A) | 9,50 % | 20.085.806 | +2,00 pp | |
| 14.11.2025 | Darwin Global Management, Ltd. | Passiv (13G/A) | 9,70 % | 20.457.445 | +1,20 pp | |
| 14.11.2025 | T. Rowe Price Associates, Inc. | Passiv (13G/A) | 3,30 % | 6.932.009 | -2,60 pp | |
| 04.09.2025 | JPMORGAN CHASE & CO. | Passiv (13G/A) | 10,80 % | 23.014.584 | +2,90 pp | |
| 14.08.2025 | T. Rowe Price Associates, Inc. | Passiv (13G/A) | 5,90 % | 11.230.934 | Neu | |
| 30.07.2025 | JPMORGAN CHASE & CO. | Passiv (13G) | 7,90 % | 15.164.893 | Neu | |
| 17.07.2025 | BlackRock, Inc. | Passiv (13G/A) | 5,10 % | 9.729.641 | Neu | |
| 15.05.2025 | Dr. Abhishek Trehan | Passiv (13G/A) | 8,50 % | 15.397.975 | +1,30 pp | |
| 15.05.2025 | Darwin Global Management, Ltd. | Passiv (13G/A) | 8,50 % | 15.397.975 | +1,30 pp | |
| 15.05.2025 | Darwin Global Master Fund, Ltd. | Passiv (13G/A) | 7,50 % | 13.547.617 | +1,10 pp | |
| 14.02.2025 | Dr. Abhishek Trehan | Passiv (13G/A) | 7,20 % | 12.960.538 | +1,50 pp | |
| 14.02.2025 | Darwin Global Master Fund, Ltd. | Passiv (13G/A) | 6,40 % | 11.480.655 | +1,00 pp | |
| 14.02.2025 | Darwin Global Management, Ltd. | Passiv (13G/A) | 7,20 % | 12.960.538 | +1,50 pp | |
| 08.01.2025 | The Vanguard Group | Passiv (13G/A) | 10,18 % | 18.218.973 | +0,31 pp | |
| 14.11.2024 | T. ROWE PRICE ASSOCIATES, INC. | Passiv (13G/A) | 7,30 % | 12.580.981 | -0,20 pp | |
| 03.09.2024 | Darwin Global Management, Ltd. | Passiv (13G) | 5,70 % | 9.717.822 | Neu | |
| 03.09.2024 | Darwin Global Master Fund, Ltd. | Passiv (13G) | 5,40 % | 9.314.373 | Neu | |
| 03.09.2024 | Dr. Abhishek Trehan | Passiv (13G) | 5,70 % | 9.717.822 | Neu | |
| 16.02.2024 | T. Rowe Price Investment Management, Inc. | Passiv (13G/A) | 4,10 % | 5.850.606 | 0,00 pp | |
| 14.02.2024 | T. Rowe Price Investment Management, Inc. | Passiv (13G) | 4,10 % | 5.850.606 | -2,10 pp | |
| 14.02.2024 | T. ROWE PRICE ASSOCIATES, INC. | Passiv (13G/A) | 7,50 % | 10.779.225 | +0,10 pp | |
| 13.02.2024 | The Vanguard Group | Passiv (13G/A) | 9,87 % | 14.125.521 | -0,20 pp | |
| 25.01.2024 | . BlackRock, Inc. | Passiv (13G/A) | 8,00 % | 11.492.282 | -0,20 pp | |
| 22.01.2024 | : STATE STREET CORPORATION | Passiv (13G/A) | 4,15 % | 0 | -0,93 pp | |
| 13.11.2023 | The Vanguard Group | Passiv (13G/A) | 10,07 % | 14.410.356 | +0,44 pp | |
| 14.02.2023 | T. Rowe Price Investment Management, Inc. | Passiv (13G) | 6,20 % | 8.374.675 | Neu | |
| 14.02.2023 | Anthony Joonkyoo Yun, MD | Passiv (13G/A) | 4,33 % | 5.871.291 | -0,76 pp | |
| 14.02.2023 | Patrick Lee, MD | Passiv (13G/A) | 4,33 % | 5.871.291 | -0,76 pp | |
| 14.02.2023 | Palo Alto Investors LP | Passiv (13G/A) | 4,33 % | 5.871.291 | -0,76 pp | |
| 14.02.2023 | PAI LLC | Passiv (13G/A) | 4,33 % | 5.871.291 | -0,76 pp | |
| 14.02.2023 | T. ROWE PRICE ASSOCIATES, INC. | Passiv (13G/A) | 7,40 % | 9.977.911 | -0,30 pp |
US Congress Trades (STOCK Act)
| Datum | Mitglied | Partei | Kammer | Typ | Betrag-Bereich |
|---|---|---|---|---|---|
| 03.10.2025 | Gilbert Cisneros | – | House | Verkauf | $1,001 – $15,000 |
| 16.06.2025 | Josh Gottheimer | – | House | Kauf | $1,001 – $15,000 |
Quelle: House eFD & Senate eFD (STOCK Act PTR). Betragsangaben sind Bereichsangaben — keine Exaktwerte. Tiefenanalyse für diese Aktie → · Alle Kongress-Bestände →
Stammdaten
Insmed Incorporated, ein biopharmazeutisches Unternehmen, entwickelt und vermarktet Therapien für Patienten mit ernsthaften und seltenen Erkrankungen. Das Unternehmen bietet ARIKAYCE für die Behandlung von Mycobacterium avium complex Lungenerkrankung als Teil eines Kombinationsantibiotika-Behandlungsschemas für erwachsene Patienten an. Es entwickelt auch Brensocatib, einen oralen reversiblen Inhibitor der Dipeptidylpeptidase 1 für die Behandlung von Patienten mit Bronchiektase und anderen Neutrophil-vermittelten Erkrankungen; und Treprostinil Palmitil Inhalationspulver, eine inhalierbare Formulierung eines Treprostinil-Prodrugs Treprostinil Palmitil für die Behandlung von pulmonaler arterieller Hypertonie und anderen seltenen Lungenerkrankungen. Insmed Incorporated wurde 1988 gegründet und hat seinen Hauptsitz in Bridgewater, New Jersey.
Unternehmen & Branche
| Name | INSMED Inc |
|---|---|
| Ticker | INSM |
| CIK | 0001104506 |
| Boerse | Nasdaq |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 457669307 |
|---|---|
| ISIN | US4576693075 |
| Typ | Common Stock |
| Marktkapitalisierung | 19,69 Mrd. USD |
| Beta | 0,86 |
Bewertung
| KBV (P/B) | 26,64 vs. 7,88 (2021) ▲ |
|---|---|
| KUV (P/S) | 32,46 vs. 17,16 (2021) ▲ |
| FCF-Rendite | -4,9 % vs. -11,5 % (2021) ▲ |
Qualität & Bilanz
| Bruttomarge | 79,7 % vs. 76,6 % (2021) ▲ |
|---|---|
| Operative Marge | -205,6 % vs. -199,0 % (2021) ▼ |
| Nettomarge | -210,5 % vs. -230,6 % (2021) ▲ |
| ROIC | -96,3 % vs. -42,5 % (2021) ▼ |
| Zinsdeckungsgrad | -14,9 vs. -9,3 (2021) ▼ |
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2021 | 2022 | 2023 | 2024 | 2025 | Verlauf |
|---|---|---|---|---|---|---|
| Bewertung | ||||||
| KBV (P/B) | 7,88 | 30,82 | – | 43,40 | 50,46 | |
| KUV (P/S) | 17,16 | 11,05 | 15,03 | 34,05 | 61,49 | |
| FCF-Rendite | -11,5 % | -15,1 % | -12,0 % | -5,7 % | -2,6 % | |
| Qualität & Bilanz | ||||||
| Bruttomarge | 76,6 % | 77,5 % | 78,5 % | 76,4 % | 79,7 % | |
| Operative Marge | -199,0 % | -186,4 % | -232,5 % | -241,5 % | -205,6 % | |
| Nettomarge | -230,6 % | -196,3 % | -245,6 % | -251,2 % | -210,5 % | |
| ROIC | -42,5 % | -38,0 % | -86,0 % | -63,7 % | -96,3 % | |
| Zinsdeckungsgrad | -9,3 | -17,3 | -8,7 | -10,3 | -14,9 | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Finanzkennzahlen (SEC XBRL) ⓘ
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | 305.964.000 | -163.563.000 | -0,76 | 2.075.863.000 | 704.852.000 |
| 2025-12-31 | 10-K | 606.423.000 | -1.276.775.000 | -6,42 | 2.264.558.000 | 738.976.000 |
| 2025-09-30 | 10-Q | 142.342.000 | -370.021.000 | -1,75 | 2.360.736.000 | 945.571.000 |
| 2025-06-30 | 10-Q | 107.415.000 | -321.686.000 | -1,70 | 2.479.857.000 | 1.249.735.000 |
| 2025-03-31 | 10-Q | 92.823.000 | -256.583.000 | -1,42 | 1.802.735.000 | 99.159.000 |
| 2024-12-31 | 10-K | 363.707.000 | -913.772.000 | -5,57 | 2.025.231.000 | 285.379.000 |
| 2024-09-30 | 10-Q | 93.425.000 | -220.524.000 | -1,27 | 2.052.972.000 | 483.415.000 |
| 2024-06-30 | 10-Q | 90.340.000 | -300.609.000 | -1,94 | 1.810.118.000 | 38.818.000 |
| 2024-03-31 | 10-Q | 75.500.000 | -157.091.000 | -1,06 | 1.159.095.000 | -464.808.000 |
| 2023-12-31 | 10-K | 305.208.000 | -749.567.000 | -5,34 | 1.329.837.000 | -331.923.000 |
| 2023-09-30 | 10-Q | 79.072.000 | -158.933.000 | -1,11 | 1.324.873.000 | -289.357.000 |
| 2023-06-30 | 10-Q | 77.229.000 | -244.809.000 | -1,78 | 1.439.139.000 | -155.745.000 |
| 2023-03-31 | 10-Q | 65.214.000 | -159.764.000 | -1,17 | 1.517.717.000 | -44.653.000 |
| 2022-12-31 | 10-K | 245.358.000 | -481.534.000 | -3,91 | 1.656.435.000 | 87.951.000 |
| 2022-09-30 | 10-Q | 67.730.000 | -131.145.000 | -1,09 | 994.817.000 | -29.959.000 |
| 2022-06-30 | 10-Q | 65.221.000 | -95.645.000 | -0,80 | 1.053.354.000 | 44.241.000 |
| 2022-03-31 | 10-Q | 53.107.000 | -94.621.000 | -0,80 | 1.153.315.000 | 119.880.000 |
| 2021-12-31 | 10-K | 188.461.000 | -434.654.000 | -3,88 | 1.243.508.000 | 410.468.000 |
| 2021-09-30 | 10-Q | 46.757.000 | -112.714.000 | -0,96 | 1.311.771.000 | 504.842.000 |
| 2021-06-30 | 10-Q | 45.366.000 | -117.321.000 | -1,07 | 1.229.783.000 | 531.053.000 |
Umsatz nach Segmenten & Regionen ⓘ
Geschäftssegmente
| Segment | FY 2025 | FY 2024 | FY 2023 | FY 2022 | Anteil | Δ | Trend |
|---|---|---|---|---|---|---|---|
| ARIKAYCE | 433,8 Mio. | – | – | – | 71,5 % | Neu | |
| BRINSUPRI | 172,7 Mio. | – | – | – | 28,5 % | Neu | |
| Reportable Segment | – | 363,7 Mio. | 305,2 Mio. | 245,4 Mio. | – | – |
Regionen
| Region | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | Anteil | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| US | 453,0 Mio. | 254,8 Mio. | 224,2 Mio. | 186,0 Mio. | 159,5 Mio. | 74,7 % | +77,8% | |
| Non Us | 153,5 Mio. | – | – | – | – | 25,3 % | Neu | |
| JP | – | 87,7 Mio. | 65,7 Mio. | 56,5 Mio. | 16,0 Mio. | – | – | |
| Europe And The Rest Of The World | – | 21,2 Mio. | 15,3 Mio. | 2,9 Mio. | 12,9 Mio. | – | – |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 07.05.2026 | 306,0 Mio. USD | -0,76 |
| Q3 2025 | 30.09.2025 | 30.10.2025 | 142,3 Mio. USD | -1,75 |
| Q2 2025 | 30.06.2025 | 07.08.2025 | 107,4 Mio. USD | -1,70 |
| Q1 2025 | 31.03.2025 | 07.05.2026 | 92,8 Mio. USD | -1,42 |
| Q3 2024 | 30.09.2024 | 30.10.2025 | 93,4 Mio. USD | -1,27 |
| Q2 2024 | 30.06.2024 | 07.08.2025 | 90,3 Mio. USD | -1,94 |
| Q1 2024 | 31.03.2024 | 08.05.2025 | 75,5 Mio. USD | -1,06 |
| Q3 2023 | 30.09.2023 | 31.10.2024 | 79,1 Mio. USD | -1,11 |
| Q2 2023 | 30.06.2023 | 08.08.2024 | 77,2 Mio. USD | -1,78 |
Einreichungs-Historie (10-K / 10-Q)
SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte
(10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 07.05.2026 | 10-Q | – | – | SEC » |
| 19.02.2026 | 10-K | 31.12.2025 | 50 Tage | SEC » |
| 30.10.2025 | 10-Q | 30.09.2025 | 30 Tage | SEC » |
| 07.08.2025 | 10-Q | 30.06.2025 | 38 Tage | SEC » |
| 08.05.2025 | 10-Q | 31.03.2025 | 38 Tage | SEC » |
| 20.02.2025 | 10-K | 31.12.2024 | 51 Tage | SEC » |
| 31.10.2024 | 10-Q | 30.09.2024 | 31 Tage | SEC » |
| 08.08.2024 | 10-Q | 30.06.2024 | 39 Tage | SEC » |
| 09.05.2024 | 10-Q | 31.03.2024 | 39 Tage | SEC » |
| 22.02.2024 | 10-K | 31.12.2023 | 53 Tage | SEC » |
| 26.10.2023 | 10-Q | 30.09.2023 | 26 Tage | SEC » |
| 03.08.2023 | 10-Q | 30.06.2023 | 34 Tage | SEC » |
| 04.05.2023 | 10-Q | 31.03.2023 | 34 Tage | SEC » |
| 23.02.2023 | 10-K | 31.12.2022 | 54 Tage | SEC » |
| 27.10.2022 | 10-Q | 30.09.2022 | 27 Tage | SEC » |
| 04.08.2022 | 10-Q | 30.06.2022 | 35 Tage | SEC » |
| 05.05.2022 | 10-Q | 31.03.2022 | 35 Tage | SEC » |
| 17.02.2022 | 10-K | 31.12.2021 | 48 Tage | SEC » |
| 28.10.2021 | 10-Q | 30.09.2021 | 28 Tage | SEC » |
| 05.08.2021 | 10-Q | 30.06.2021 | 36 Tage | SEC » |
| 06.05.2021 | 10-Q | 31.03.2021 | 36 Tage | SEC » |
| 25.02.2021 | 10-K | 31.12.2020 | 56 Tage | SEC » |
| 29.10.2020 | 10-Q | 30.09.2020 | 29 Tage | SEC » |
| 06.08.2020 | 10-Q | 30.06.2020 | 37 Tage | SEC » |
Kritische 8-K Meldungen ⓘ
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 19.02.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | n such a filing. ITEM 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain… |
| 16.05.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ITEM 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 17.04.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ITEM 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 20.02.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | e in such a filing. ITEM 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of… |
| 13.05.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ITEM 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 11.05.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ITEM 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 23.05.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ITEM 5.02 - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 13.05.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ITEM 5.02 - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 17.02.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 22.06.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 18.05.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ITEM 5.02 - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 14.05.2020 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ITEM 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 02.04.2020 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 30.01.2020 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ITEM 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-05-13 | 11.691 | 116,00 | 1.356.156 |
| 2026-05-08 | 224.501 | 105,00 | 23.572.605 |
| 2026-04-20 | 139.933 | 144,48 | 20.217.520 |
| 2026-04-16 | 3 | 146,74 | 440 |
| 2026-04-09 | 358 | 160,18 | 57.344 |
| 2026-04-06 | 6 | 162,43 | 975 |
| 2026-03-23 | 7 | 136,00 | 952 |
| 2026-03-10 | 206 | 143,13 | 29.485 |
| 2026-03-04 | 10 | 147,00 | 1.470 |
| 2026-03-03 | 67 | 146,32 | 9.803 |
| 2026-02-27 | 41 | 150,00 | 6.150 |
| 2026-02-26 | 2.007 | 148,61 | 298.260 |
| 2026-02-23 | 421 | 164,91 | 69.427 |
| 2026-02-19 | 922 | 151,11 | 139.323 |
| 2026-02-18 | 62 | 150,52 | 9.332 |
| 2026-02-12 | 11.161 | 148,43 | 1.656.627 |
| 2026-02-11 | 1.791 | 148,55 | 266.053 |
| 2026-02-06 | 1.432 | 151,03 | 216.275 |
| 2026-02-05 | 1.412 | 152,44 | 215.245 |
| 2026-01-27 | 4 | 159,72 | 639 |
| 2026-01-26 | 362 | 156,21 | 56.548 |
| 2026-01-16 | 10 | 159,27 | 1.593 |
| 2026-01-12 | 6 | 175,97 | 1.056 |
| 2026-01-08 | 568 | 176,00 | 99.968 |
| 2026-01-06 | 1 | 175,20 | 175 |
| 2025-12-22 | 22.993 | 174,84 | 4.020.096 |
| 2025-12-15 | 4.886 | 197,01 | 962.591 |